Your browser doesn't support javascript.
loading
Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.
Preston, Joshua D; Jansen, Caroline S; Kosaraju, Siddhartha; Niyogusaba, Tim; Zhuang, Tony Z; Iwamoto, Sally W; Hutto, Spencer K; Lechowicz, Mary Jo; Allen, Pamela B.
Afiliação
  • Preston JD; Medical Scientist Training Program, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Jansen CS; Nutrition & Health Sciences, Laney Graduate School, Emory University, Atlanta, GA 30322, USA.
  • Kosaraju S; Medical Scientist Training Program, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Niyogusaba T; Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Zhuang TZ; Division of Neuroradiology, Department of Radiology & Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Iwamoto SW; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Hutto SK; Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Lechowicz MJ; Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Allen PB; Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
CNS Oncol ; 12(4): CNS105, 2023 12 01.
Article em En | MEDLINE | ID: mdl-37877303
Cutaneous T-cell lymphoma (CTCL) is a rare cancer of the blood, which typically manifests with skin lesions, such as itchy, scaly rashes that may thicken to form tumors on the skin. Though uncommon, metastases do occur in CTCL. A particularly rare location for these metastases is the central nervous system. This case series recounts the story of four unique patients and the presentation, diagnosis, and treatment of their CTCL, which unfortunately progressed to involve the central nervous system. Outcomes with central nervous system involvement in CTCL are poor, but may occur sometime later than a patient's initial diagnosis. Our patients had a median time from initial diagnosis to central nervous system metastases of ∼5.4 years and a survival of ∼160 days after central nervous system metastases. Some types of therapy, such as radiation, surgery, or chemotherapy, may be beneficial in extending survival or providing symptomatic relief for patients. It can be difficult to recognize symptoms of central nervous system metastases, so this case series emphasizes that vigilance for potential metastases and use of interdisciplinary teams is important in caring for these patients. This case series demonstrates the importance of continued research in this area, with the hope of improving outcomes for patients with central nervous system metastases of CTCL.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfoma Cutâneo de Células T / Segunda Neoplasia Primária Limite: Humans Idioma: En Revista: CNS Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfoma Cutâneo de Células T / Segunda Neoplasia Primária Limite: Humans Idioma: En Revista: CNS Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido